Murray Healthcare expects net profit to increase by more than 35% in the first three quarters to exceed $6 billion for the full year.

On the evening of October 16th, Meirui Medical announced that it expects to achieve operating income of RMB14,855 million to RMB16,093 million in the first three quarters of this year, up 20% to 30% YoY;
, the company's first three quarters of this year may have exceeded last year's full-year net profit of 4.681 billion yuan in 2019.
Return to steady growth in the third quarter According to the Meirui Medical Announcement, operating income is expected to reach RMB5 billion to RMB5.426 billion in the third quarter, up 20% to 30% YoY, and net profit attributable to shareholders of listed companies is RMB1,758 million to RMB1.888 billion, up 35% to 45% YoY.
the second half of 2018, Myer Medical's net profit has grown year-on-year for nine consecutive quarters, mostly between 28% and 38%.
's net profit grew 30 percent in the first quarter of this year as the company struggled to push for a rapid resumption of work, rising 56.99 percent strongly in the second quarter as the outbreak spread around the world, and is expected to return to normal growth in the third quarter.
Meirui Medical said in the announcement, entering the third quarter, by the impact of the new crown epidemic continued to spread around the world, the international market for related anti-epidemic products such as monitors, ventilators, infusion pumps, new crown antibody reagents, portable color super, mobile DR demand remains at a high level, the company's product influence is also increasing;
the international epidemic situation is still unclear, the international market demand for anti-epidemic products remains.
expects full-year operating income of RMB19.87 billion to RMB21.52 billion in 2020, up 20% to 30% year-on-year, and net profit attributable to shareholders of the parent company is expected to be RMB6.08 billion to RMB6.55 billion, up 30% to 40% year-on-year.
growth was also in keeping with the previous three quarters.
Murray Medical is mainly engaged in medical device research and development, manufacturing, marketing and services, has always been customer demand-oriented, committed to providing products and services to medical institutions around the world, the main products cover life information and support, in-body diagnosis and medical imaging three areas.
, chairman of the Shenzhen Special Economic Zone, together with Ma Huateng, Ma Mingzhe and others, was named "Shenzhen Special Economic Zone 40th anniversary of the establishment of innovative and entrepreneurial figures and advanced role models."
research, as one of the important anti-epidemic products providers in China, has attracted a lot of attention.
, the company has been under institutional research for several days since the end of August, according to Myer Healthcare's investor relations activity records.
, 207 institutions and 286 participants participated in the survey, which was conducted from 7 September to 16 September.
the company's overseas customer development, order situation, product prices and domestic market conditions are the most important issues of concern to the organization.
Meri Medical said that because the first wave of outbreaks in most developing countries has not yet eased, and some european countries have recently experienced a certain degree of repetition of the outbreak, including monitors, ventilators, infusion pumps, portable ultrasound and other anti-epidemic equipment is still in high demand.
prices of these products, although labor, logistics, raw materials and other costs have increased during the outbreak, but the company did not do any price increases on the product behavior.
Murray Medical in the first half of the international market has achieved a cumulative breakthrough of nearly 400 high-end customer base, and the company since the export of products in the past 20 years to achieve the breakthrough of overseas high-end hospitals is not more than 600, and these 400 customers breakthrough is more difficult, the company's brand promotion is therefore at least five years ahead of schedule.
companies in the future in various countries in the medical replacement board construction is expected to get more opportunities.
continued to grow, Myer Healthcare's share price hit new highs.
as of October 14, Myer Medical had gained 111.19 per cent so far this year, with its latest market capitalisation of 464.4 billion yuan.
.